Astrana Health Inc. (ASTH) exhibits 45.0% gross margins and 4.6% return on invested capital within Consumer Discretionary (Professional Services), balanced against a 27.3x enterprise multiple and 4.8% implied options volatility.
Sustained 45.0% gross profitability converts into 2.5% operating margin and 4.6% ROIC, outpacing sector cost of capital.
ROIC: 4.6% // GM: 45.0%YoY revenue trajectory of +56.4% paired with 5.75% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +56.4% // FCF YLD: 5.75%Altman Z-Score of 2.54 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.54 // F-SCORE: 6/9Trading at 75.7x trailing P/E (63.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 75.7x // EV/EBITDA: 27.3xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $36.62 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Professional Services require continuous execution to defend 0.8% net margins.
NET MARGIN: 0.8% // D/E: 1.27x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ASTH & activate live FRED threshold breach alerts.